Skip to main content
. 2019 Apr;60(4):413–419. doi: 10.1165/rcmb.2018-0175OC

Table 1.

Patient Characteristics

  Eosinophilic Neutrophilic Paucigranulocytic
Number 5 4 5
Age (± SEM) 11.2 ± 1.4 4.5 ± 1.8 8.3 ± 2.1
Male sex, n (%) 3 (60%) 3 (75%) 3 (60%)
Present atopy, n (%) 4 (80%) 2 (50%) 2 (40%)
Eosinophils (%) 4 ± 1 0 ± 0 0 ± 0
PMNs (%) 2 ± 1 34 ± 5 1 ± 1
Mononuclear phagocytes (%) 69 ± 6 54 ± 2 71 ± 10
Serum IgE (median [25th–75th percentile]) 330 (63–1,662) 101 (18–288) 30 (12–894)
AEC (median [25th–75th percentile]) 593 (415–768) 355 (115–835) 180 (100–215)
ACT (mean ± SEM) 13.2 ± 1.7 20.0 ± 3.5 15 ± 1.5
ICU admission history (n) 3 0 2
Daily prednisone use (n) 3 0 1
ICS (fluticasone equivalents μg/d; median [25th–75th percentile]) 800 (160–800) 330 (160–725) 480 (160–890)
Pre-FEV1/FVC (± SEM) 0.76 ± 0.05 0.89* 0.81 ± 0.05
Post-FEV1/FVC (± SEM) 0.83 ± 0.05 ND 0.87 ± 0.03

Definition of abbreviations: AEC = absolute eosinophil count; ACT = asthma control test; FEV1 = forced expiratory volume in 1 second; FVC = forced vital capacity; ICS = inhaled corticosteroid; ND = not done; PMNs = polymorphonuclear leukocytes.

*

Only one subject was old enough to participate in spirometry.